N
Neurode
Health Tech & Medtech · Sydney, Australia · Founded 2021
Drug free, non-invasive treatment of ADHD MoreLess
Neurode Labs operates in the cutting-edge field of brain-computer interfaces (BCIs), focusing on enhancing cognitive function and emotional well-being. The company serves a diverse range of clients, including individuals seeking cognitive enhancement, healthcare providers, and research institutions. Neurode Labs operates in the health tech market, leveraging advanced algorithms and optical systems to develop its products. The business model is primarily B2C (business-to-consumer), selling its products directly to end-users through its website and other online platforms. Revenue is generated through the sale of its BCI devices and related software subscriptions. The company's innovative approach aims to provide non-invasive solutions that help users improve their mental health and cognitive abilities.
Keywords: brain-computer interface, cognitive enhancement, emotional well-being, health tech, advanced algorithms, optical systems, B2C, non-invasive solutions, mental health, cognitive abilities.
Company overview
Neurode company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2021
- Headquarters
- Sydney, Australia
- Employees
- 13
- Open positions
- None listed
- Dealroom signal
- 65.3
Valuation & funding
Neurode funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | May 2025 | $10M | $40M | Undisclosed | ↗ |
| SEED✓Equity / VC | Sep 2024 | $3.5M | $14M | PsyMed Ventures · Khosla Ventures | ↗ |
| SEED✓Equity / VC | May 2023 | $32K | $129K | CSIRO Kick-Start | — |
| SEEDEquity / VC | Jun 2021 | — | — | Hax · SOSV | — |
| SPINOUT✓Other financing | Jan 2021 | $0 | — | University of New South Wales | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $200K | 0% | 13 |
| 2025 | $200K | 0% | 14 |
| 2024 | $200K | 0% | 12 |
| 2023 | $200K | +33.3% | 7 |
| 2022 | $150K | — | 4 |
Growth signals
Neurode website traffic
Latest recorded traffic for Neurode is 7.7K monthly website visits, down 48.7% over the last three months. Neurode's team declined 7.1% over the past year.
Comparisons
Neurode compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Neurode's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Neurode has talent and traffic
team presence
In the news
Latest news about Neurode
Recent press, funding announcements, and product moves mentioning Neurode — open to read from the original sources.
Market sentiment
What the market is saying about Neurode
An AI-synthesized read of the highest-engagement posts about Neurode on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Neurode’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.